Академический Документы
Профессиональный Документы
Культура Документы
ROMA
ROMA (Premenopausal) 9.64 % <7.40
Interpretation
----------------------------------------------------------
| MENOPAUSAL STATUS | REFERENCE RANGE OF HE4 IN pmol/L |
|-----------------------|----------------------------------|
| Premenopausal females | <70 |
|-----------------------|----------------------------------|
| Postmenopausal females| <140 |
----------------------------------------------------------
-----------------------------------------------------------------------
| MENOPAUSAL STATUS |ROMA IN % | RISK OF EPITHELIAL OVARIAN CANCER |
|-----------------------|----------|------------------------------------|
| Premenopausal females | <7.4 | Low risk |
| | >=7.4 | High risk |
|-----------------------|----------|------------------------------------|
| Postmenopausal females| <25.3 | Low risk |
| | >=25.3 | High risk |
----------------------------------------------------------------------
Note
1. This assay is intended for use in women who are >18 years of age, have an ovarian mass with
planned surgery and not yet referred to an oncologist.
2. The test should not be used in women with Rheumatoid factor concentration >250 IU/mL, patients
previously treated for malignancy or presently on chemotherapy.
3. This assay is not intended to be used as a screening test to determine requirement of surgery in a
patient.
4. All results should be correlated with clinical / radiological evaluation.
Comments
Risk of ovarian malignancy algorithm (ROMA) should be used as a supplement to the standard pre-surgical
evaluation of a patient to assess likelihood of malignancy prior to surgery specially in those cases where
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)
*140927586* Page 1 of 2
.
IMPORTANT INSTRUCTIONS
*Test results released pertain to the specimen submitted .*All test results are dependent on the quality of the sample received by the Laboratory .
*Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .*Sample
repeats are accepted on request of Referring Physician within 7 days post reporting.*Report delivery may be delayed due to unforeseen
circumstances. Inconvenience is regretted.*Certain tests may require further testing at additional cost for derivation of exact value. Kindly submit
request within 72 hours post reporting.*Test results may show interlaboratory variations .*The Courts/Forum at Delhi shall have exclusive
jurisdiction in all disputes/claims concerning the test(s) & or results of test(s).*Test results are not valid for medico legal purposes. * Contact
customer care Tel No. +91-11-39885050 for all queries related to test results.
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)
*140927586* Page 2 of 2